2m 2m 2m 2m 2m 2m 2m
IDEAYA BIOSCIENC (IDYA)
NASDAQ
$34.94+$0.71 (+2.07%)
Price as of Jun 23, 2026 5:39 PM EDT- $3.2BMarket Cap
- 59.80%1-Year Change
- BiotechnologyIndustry
IDEAYA BIOSCIENC (IDYA)
$34.94+$0.71 (+2.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 218.7M +3,024.43% | 7.0M -70.07% | 23.4M -54.08% | 50.9M +82.28% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 218.7M +3,024.43% | 7.0M -70.07% | 23.4M -54.08% | 50.9M +82.28% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -314.7M +6.80% | -294.7M +127.53% | -129.5M +44.64% | -89.5M +53.95% | |
Depreciation and Amortization Expense | 2.7M +13.11% | 2.4M -3.59% | 2.5M +17.85% | 2.1M +21.80% | |
Total Operating Expenses | 378.0M +13.19% | 334.0M +111.63% | 157.8M +39.13% | 113.4M +45.04% | |
Operating Profit | -159.3M -51.28% | -327.0M +143.23% | -134.4M +115.08% | -62.5M +24.34% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 45.6M -13.11% | 52.5M +144.54% | 21.5M +458.05% | 3.8M +660.28% | |
Income before Taxes | -159.3M -51.28% | -327.0M +143.23% | -134.4M +115.08% | -62.5M +24.34% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -113.7M -58.58% | -274.5M +142.98% | -113.0M +92.59% | -58.7M +17.87% | |
Net Income from Continuing Operations Applicable to Common | -113.7M -58.58% | -274.5M +142.98% | -113.0M +92.59% | -58.7M +17.87% | |
Basic EPS and Net Income | -1.28 -61.90% | -3.36 +71.43% | -1.96 +38.03% | -1.42 +0.71% | |
Diluted EPS and Net Income | -1.28 -61.90% | -3.36 +71.43% | -1.96 +38.03% | -1.42 +0.71% | |
Basic Weighted Average Shares | 88.5M +8.33% | 81.7M +42.00% | 57.5M +38.79% | 41.4M +17.57% | |
Diluted Weighted Average Shares | 88.5M +8.33% | 81.7M +42.00% | 57.5M +38.79% | 41.4M +17.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 112.8M +33.71% | 84.4M -46.26% | 157.0M +128.78% | 68.6M -25.44% | |
Short-Term Investments | 526.6M -11.04% | 591.9M +60.81% | 368.1M +24.27% | 296.2M +91.44% | |
Cash and Cash Equivalents and Short-Term Investments | 639.4M -5.46% | 676.3M +28.79% | 525.1M +43.93% | 364.8M +47.84% | |
Total Current Assets | 666.7M -3.33% | 689.7M +29.49% | 532.6M +43.78% | 370.5M +47.59% | |
Accumulated Depreciation | 14.3M +21.73% | 11.7M +21.85% | 9.6M +27.25% | 7.6M +34.95% | |
Property and Plant and Equipment and Net | 8.2M -8.35% | 9.0M +45.46% | 6.2M -5.30% | 6.5M +36.66% | |
Total Long-Term Assets | 418.5M +1,673,956.00% | 25,000 0.00% | 25,000 -74.75% | 99,000 -65.98% | |
Total Assets | 1.1B -1.31% | 1.1B +73.12% | 649.3M +67.36% | 388.0M +1.74% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 58.8M +27.66% | 46.1M +70.00% | 27.1M -14.56% | 31.7M -29.76% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 27.6M +46.11% | 18.9M +199.10% | 6.3M -7.15% | 6.8M +56,533.33% | |
Total Liabilities | 86.4M +33.02% | 64.9M +130.09% | 28.2M -26.71% | 38.5M -51.76% | |
Retained Earnings | -736.5M +18.25% | -622.8M +78.79% | -348.4M +47.99% | -235.4M +33.19% | |
Total Stockholders Equity | 1.0B -3.42% | 1.1B +70.53% | 621.1M +77.73% | 349.5M +15.90% | |
Total Shares Outstanding | 87.8M +1.49% | 86.5M +33.00% | 65.0M +34.96% | 48.2M +25.07% | |
Cash Flow | |||||
Cash from Operating Activities | -71.1M -71.28% | -247.6M +114.87% | -115.2M +32.18% | -87.2M +56.29% | |
Capital Expenditures | 2.4M -38.61% | 3.9M +62.88% | 2.4M -31.22% | 3.4M +30.22% | |
Cash from Investing Activities | 70.0M +113.92% | -502.6M +217.16% | -158.5M +374.36% | -33.4M -52.05% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 29.8M -95.60% | 677.6M +86.80% | 362.7M +273.30% | 97.2M -33.20% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -72.84% -98.44% | -4,671.07% +712.57% | -574.85% +368.43% | -122.72% -31.79% | |
Return on Assets | -10.18% -67.11% | -30.95% +42.12% | -21.78% +42.83% | -15.25% +4.13% | |
Return on Equity | -10.92% -66.57% | -32.67% +40.35% | -23.28% +29.17% | -18.02% -9.50% | |
Revenue Growth | 3,024.43% +4,416.52% | -70.07% +29.55% | -54.08% -165.73% | 82.28% +91.31% | |
Current Ratio | 11.34 -24.28% | 14.97 -23.83% | 19.65 +68.27% | 11.68 +110.14% | |
Cash Ratio | 1.92 +4.74% | 1.83 -68.39% | 5.79 +167.76% | 2.16 +6.16% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow